These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8522386)
21. Problems and controversies in the management of hematogenous candidiasis. Uzun O; Anaissie EJ Clin Infect Dis; 1996 May; 22 Suppl 2():S95-101. PubMed ID: 8722835 [TBL] [Abstract][Full Text] [Related]
22. Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study. Infection; 2004 Jun; 32(3):8. PubMed ID: 15230277 [No Abstract] [Full Text] [Related]
23. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia. Odds FC Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766 [No Abstract] [Full Text] [Related]
24. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. Nguyen MH; Clancy CJ; Yu VL; Yu YC; Morris AJ; Snydman DR; Sutton DA; Rinaldi MG J Infect Dis; 1998 Feb; 177(2):425-30. PubMed ID: 9466531 [TBL] [Abstract][Full Text] [Related]
25. Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. Swanson H; Hughes PA; Messer SA; Lepow ML; Pfaller MA J Pediatr; 1996 Nov; 129(5):688-94. PubMed ID: 8917235 [TBL] [Abstract][Full Text] [Related]
26. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Jandourek A; Brown P; Vazquez JA Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825 [No Abstract] [Full Text] [Related]
27. Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS. Tumbarello M; Bevilacqua N; Federico G; Morace G; Cauda R; Tacconelli E Clin Infect Dis; 1996 Jan; 22(1):179-80. PubMed ID: 8824996 [No Abstract] [Full Text] [Related]
28. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J; Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765 [TBL] [Abstract][Full Text] [Related]
29. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357 [TBL] [Abstract][Full Text] [Related]
30. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B]. Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039 [TBL] [Abstract][Full Text] [Related]
31. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients]. Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669 [TBL] [Abstract][Full Text] [Related]
32. Candida catenulata fungemia in a cancer patient. Radosavljevic M; Koenig H; Letscher-Bru V; Waller J; Maloisel F; Lioure B; Herbrecht R J Clin Microbiol; 1999 Feb; 37(2):475-7. PubMed ID: 9889248 [TBL] [Abstract][Full Text] [Related]
33. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Pachl J; Svoboda P; Jacobs F; Vandewoude K; van der Hoven B; Spronk P; Masterson G; Malbrain M; Aoun M; Garbino J; Takala J; Drgona L; Burnie J; Matthews R; Clin Infect Dis; 2006 May; 42(10):1404-13. PubMed ID: 16619152 [TBL] [Abstract][Full Text] [Related]
35. Use of amphotericin B during pregnancy: case report and review. Dean JL; Wolf JE; Ranzini AC; Laughlin MA Clin Infect Dis; 1994 Mar; 18(3):364-8. PubMed ID: 8011817 [TBL] [Abstract][Full Text] [Related]
36. Management of candida septicaemia in a regional burn unit. Still JM; Belcher K; Law EJ Burns; 1995 Dec; 21(8):594-6. PubMed ID: 8747732 [TBL] [Abstract][Full Text] [Related]
37. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes). Kretschmar M; Amselem S; Zawoznik E; Mosbach K; Dietz A; Hof H; Nichterlein T Mycoses; 2001; 44(7-8):281-6. PubMed ID: 11714063 [TBL] [Abstract][Full Text] [Related]
38. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia. Cetin H; Yalaz M; Akisu M; Hilmioglu S; Metin D; Kultursay N Pediatr Int; 2005 Dec; 47(6):676-80. PubMed ID: 16354223 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601 [TBL] [Abstract][Full Text] [Related]
40. Amphotericin B lipid complex therapy in an AIDS patient with Rhodotorula rubra fungemia. Lui AY; Turett GS; Karter DL; Bellman PC; Kislak JW Clin Infect Dis; 1998 Oct; 27(4):892-3. PubMed ID: 9798050 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]